Objective: The incidence of thyroid cancer, the most common endocrine malignancy, has
increased dramatically in the last fifty years. This article will review the standard approach to …

Thyroid cancer incidence is increasing, although mortality is stable. The major cause of the
increased incidence is detection of subclinical disease–overdiagnosis. Patients are still …

Thyroid cancer is uncommon with an estimated lifetime risk of 0.8% for women and 0.3% for
men. The incidence appears to be increasing by 4% per year and is currently the eighth …

Thyroid cancer is the most common endocrine malignancy. The major histologic subtypes
for thyroid cancer is papillary, follicular, medullary, and anaplastic accounting for 80%, 10 …

Thyroid cancer is rapidly increasing in incidence, but the mortality rate remains flat. Debate
has arisen over the need to detect or treat most thyroid cancers early, given their favorable …

Background Thyroid cancer is the most common malignancy of the endocrine system,
representing 3.8% of all new cancer cases in the United States and is the ninth most …

Importance Approximately 43 720 new cases of thyroid carcinoma are expected to be
diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%. This review …

ABSTRACT Objective:(1) Describe current epidemiology of thyroid cancer in the United
States;(2) evaluate hypothesized causes of the increased incidence of thyroid cancer; and …

Abstract In 2005, approximately 1,490 cancer deaths will occur among persons living with
thyroid carcinoma in the United States. Interestingly, although thyroid carcinoma occurs …

Conclusion Thyroid cancer comprises a group of tumors with remarkably different features.
Owing to the rising incidence of thyroid cancer and recent advances in the management of …